Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 26, 2025	Sep '25 Sep 26, 2025	Sep '24 Sep 27, 2024	Sep '23 Sep 29, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 24, 2021
Cash & Equivalents	643.85	701.89	482.05	745.36	620.13	1,225
Short-Term Investments	0.74	0.7	-	139.15	189.21	38.84
Cash & Short-Term Investments	644.58	702.6	482.05	884.51	809.34	1,264
Cash Growth	23.76%	45.75%	-45.50%	9.29%	-35.98%	13.00%
Accounts Receivable	571.36	511.9	512.94	444.38	419.69	414.93
Receivables	571.36	511.9	512.94	444.38	419.69	414.93
Inventory	31.26	30.42	33.73	35.62	23.55	10.97
Prepaid Expenses	29.88	28.01	29.75	24.44	26.85	29.96
Restricted Cash	83.72	91.47	95.71	72.6	8.24	7.65
Other Current Assets	47.26	23.87	40.25	26.26	23.22	32.77
Total Current Assets	1,408	1,388	1,194	1,488	1,311	1,760
Property, Plant & Equipment	502.29	503.81	518.16	521.78	560.01	601.51
Long-Term Investments	85.02	80.21	89.27	97.81	102.51	62.82
Goodwill	530.3	529.9	533.21	408.41	365.15	340.69
Other Intangible Assets	364.02	397.06	434.51	167.43	112.27	122.89
Long-Term Deferred Tax Assets	214.35	214.36	219.76	201.86	183.57	156.02
Other Long-Term Assets	88.08	114.16	120.61	94.67	55.15	61.26
Total Assets	3,192	3,228	3,110	2,980	2,690	3,106
Accounts Payable	8.67	17.84	17.38	20.93	14.17	17.78
Accrued Expenses	175.74	195.28	171.01	179.01	143.15	157.69
Current Portion of Leases	10.33	10.38	12.24	13.63	13.26	15.4
Current Income Taxes Payable	11.21	8.93	9.05	4.77	1.27	1.33
Current Unearned Revenue	37.09	31.38	31.64	31.51	18.59	18.47
Other Current Liabilities	200.47	173.97	176.52	172.39	87.09	105.03
Total Current Liabilities	443.51	437.79	417.84	422.23	277.52	315.72
Long-Term Leases	30.31	28.49	34.75	37.02	37.69	56.72
Long-Term Unearned Revenue	25.16	29.69	34.59	40	23.2	23.71
Pension & Post-Retirement Benefits	5.47	5.32	4.95	4.3	4.13	4.88
Other Long-Term Liabilities	84.8	94.53	130.91	104.04	96	100.43
Total Liabilities	589.25	595.81	623.04	607.58	438.53	501.46
Common Stock	0.09	0.09	0.09	0.09	0.09	0.1
Retained Earnings	2,604	2,635	2,496	2,392	2,298	2,608
Comprehensive Income & Other	-10.78	-12.52	-19.19	-36.98	-51.64	-10.03
Total Common Equity	2,594	2,623	2,477	2,355	2,246	2,598
Minority Interest	9.2	9.39	9.73	17.08	4.84	6.25
Shareholders' Equity	2,603	2,632	2,487	2,372	2,251	2,604
Total Liabilities & Equity	3,192	3,228	3,110	2,980	2,690	3,106
Total Debt	40.64	38.88	46.99	50.65	50.94	72.12
Net Cash (Debt)	603.95	663.72	435.06	833.86	758.4	1,192
Net Cash Growth	26.78%	52.56%	-47.83%	9.95%	-36.38%	14.88%
Net Cash Per Share	6.21	6.81	4.47	8.53	7.44	11.39
Filing Date Shares Outstanding	95.54	95.51	95.44	95.28	95.96	101.16
Total Common Shares Outstanding	95.53	95.46	95.39	95.76	95.88	101.07
Working Capital	964.56	950.47	776.58	1,066	1,033	1,445
Book Value Per Share	27.15	27.47	25.97	24.59	23.43	25.70
Tangible Book Value	1,699	1,696	1,509	1,779	1,769	2,134
Tangible Book Value Per Share	17.79	17.76	15.82	18.58	18.45	21.12
Land	42.02	42.02	42.01	41.9	41.77	42.04
Buildings	289.94	290.92	288.91	287.8	287.54	284.15
Machinery	386.26	390.38	410.94	418.53	402.9	420.55
Construction In Progress	35.59	36.18	25.09	18.33	23.04	22.92
Leasehold Improvements	80.71	84.61	86.61	79.99	86.79	88.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.